首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

1820628

全球尿路感染試紙市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Urinary Tract Infection Test Strip Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 111 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計 2025 年至 2033 年間，全球泌尿道感染試紙市場將以 4.64% 的顯著複合年成長率成長。到 2033 年，市場規模預計將飆升至 9.7112 億美元，較 2024 年的 6.4565 億美元大幅成長。

全球泌尿道感染 (UTI) 試紙市場正經歷成長，這得益於泌尿道感染發病率的上升以及對快速即時診斷的需求。檢測白血球、亞硝酸鹽和血液的試紙可快速篩檢並輔助早期診斷。未來的創新將專注於提高靈敏度、實現多重檢測，以及與基於智慧型手機的讀取器整合，以實現數位化健康監測。

此外，抗生素抗藥性的上升以及對及時治療決策的需求正在推動市場採用。家庭醫療保健和遠距醫療服務的擴展正在提高可近性。製造和品質控制的進步正在提高檢測的可靠性。隨著診斷技術的發展，泌尿道感染試紙市場將持續創新，為感染管理提供準確、便利且使用者友好的解決方案。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第8章：泌尿道感染試紙公司的競爭格局

尿路感染試紙市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第9章：公司簡介

頂級公司市佔率分析
市場集中度
Qiagen

公司概況
公司收入
產品
最新動態

Accelerate Diagnostics Inc.

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc.

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd.

公司概況
公司收入
產品
最新動態

Danaher

公司概況
公司收入
產品
最新動態

Siemens Healthcare GmbH

公司概況
公司收入
產品
最新動態

Randox Laboratories Ltd.

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

BiomeRieux

公司概況
公司收入
產品
最新動態

T2 Biosystems Inc

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112114740

The global Urinary Tract Infection Test Strip market is forecasted to grow at a noteworthy CAGR of 4.64% between 2025 and 2033. By 2033, market size is expected to surge to USD 971.12 Million, a substantial rise from the USD 645.65 Million recorded in 2024.

The global urinary tract infection (UTI) test strip market is experiencing growth driven by increasing incidence of UTIs and demand for rapid, point-of-care diagnostics. Test strips detecting leukocytes, nitrites, and blood provide quick screening and aid in early diagnosis. Future innovations will focus on enhanced sensitivity, multiplex detection, and integration with smartphone-based readers for digital health monitoring.

Moreover, the rise of antibiotic resistance and need for timely treatment decisions are propelling market adoption. Expansion of home healthcare and telemedicine services is increasing accessibility. Advances in manufacturing and quality control are improving test reliability. As diagnostic technologies evolve, the UTI test strip market will continue to innovate, delivering accurate, convenient, and user-friendly solutions for infection management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Urinary Tract Infection Test Strip market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Urethritis
Cystitis
Pyelonephritis

By End Use

General Practitioners (GPs)
Urologists
Urogynecologists
Hospital Laboratories
Reference Laboratories
Hospital Emergency Departments
Urgent Care
Others
List of Companies Profiled in the report
Qiagen, Accelerate Diagnostics Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Danaher, Siemens Healthcare GmbH, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Biomerieux, T2 Biosystems Inc.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. URINARY TRACT INFECTION TEST STRIP - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By End Use
- 3.7.3 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Urethritis Historic and Forecast Sales By Regions
5.4. Cystitis Historic and Forecast Sales By Regions
5.5. Pyelonephritis Historic and Forecast Sales By Regions

6. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET ANALYSIS BY END USE

6.1. Overview By End Use
6.2. Historical and Forecast Data Analysis By End Use
6.3. General Practitioners (GPs) Historic and Forecast Sales By Regions
6.4. Urologists Historic and Forecast Sales By Regions
6.5. Urogynecologists Historic and Forecast Sales By Regions
6.6. Hospital Laboratories Historic and Forecast Sales By Regions
6.7. Reference Laboratories Historic and Forecast Sales By Regions
6.8. Hospital Emergency Departments Historic and Forecast Sales By Regions
6.9. Urgent Care Historic and Forecast Sales By Regions
6.10. Others Historic and Forecast Sales By Regions

7. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE URINARY TRACT INFECTION TEST STRIP COMPANIES

8.1. Urinary Tract Infection Test Strip Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF URINARY TRACT INFECTION TEST STRIP INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Qiagen
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Accelerate Diagnostics Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Bio-Rad Laboratories Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. F. Hoffmann-La Roche Ltd.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Danaher
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Siemens Healthcare GmbH
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Randox Laboratories Ltd.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Thermo Fisher Scientific Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. BiomeRieux
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. T2 Biosystems Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments